Warning! GuruFocus detected
1 Severe warning sign
with GLSI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Greenwich LifeSciences Inc
NAICS : 541714
SIC : 2834
ISIN : US3968791083
Share Class Description:
GLSI: Ordinary SharesCompare
Compare
Traded in other countries / regions
GLSI.USA Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2020-09-25Description
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.62 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -51.3 | |||||
| 3-Year EPS without NRI Growth Rate | -51.2 | |||||
| 3-Year FCF Growth Rate | -18.9 | |||||
| 3-Year Book Growth Rate | -54.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.87 | |||||
| 9-Day RSI | 54.2 | |||||
| 14-Day RSI | 48.15 | |||||
| 3-1 Month Momentum % | -14.54 | |||||
| 6-1 Month Momentum % | -18.25 | |||||
| 12-1 Month Momentum % | -15.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.62 | |||||
| Quick Ratio | 2.62 | |||||
| Cash Ratio | 2.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.42 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -313.11 | |||||
| ROA % | -266.24 | |||||
| ROIC % | -15057.37 | |||||
| 3-Year ROIIC % | -3856.08 | |||||
| ROCE % | -317.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 51.84 | |||||
| Price-to-Tangible-Book | 51.58 | |||||
| EV-to-EBIT | -7.73 | |||||
| EV-to-EBITDA | -7.73 | |||||
| EV-to-FCF | -17.03 | |||||
| Price-to-Net-Current-Asset-Value | 51.58 | |||||
| Price-to-Net-Cash | 51.58 | |||||
| Earnings Yield (Greenblatt) % | -12.94 | |||||
| FCF Yield % | -5.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GLSI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Greenwich LifeSciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.2 | ||
| Beta | 2.02 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 60.2 | ||
| 14-Day RSI | 48.15 | ||
| 14-Day ATR ($) | 0.799996 | ||
| 20-Day SMA ($) | 9.4925 | ||
| 12-1 Month Momentum % | -15.45 | ||
| 52-Week Range ($) | 8.06 - 18.7499 | ||
| Shares Outstanding (Mil) | 13.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Greenwich LifeSciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Greenwich LifeSciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Greenwich LifeSciences Inc Frequently Asked Questions
What is Greenwich LifeSciences Inc(GLSI)'s stock price today?
The current price of GLSI is $9.80. The 52 week high of GLSI is $18.75 and 52 week low is $8.06.
When is next earnings date of Greenwich LifeSciences Inc(GLSI)?
The next earnings date of Greenwich LifeSciences Inc(GLSI) is 2025-05-20 Est..
Does Greenwich LifeSciences Inc(GLSI) pay dividends? If so, how much?
Greenwich LifeSciences Inc(GLSI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers